News
The American Cancer Society (ACS) today announced a new partnership with Guardant Health (Nasdaq: GH), a leading precision ...
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth ...
Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.
StockStory.org on MSN1d
RadNet (RDNT) Reports Q2: Everything You Need To Know Ahead Of Earnings
Diagnostic imaging company RadNet (NASDAQ:RDNT) will be announcing earnings results next tomorrow after market close. Here’s ...
1d
Investor's Business Daily on MSNStocks Showing Market Leadership: Guardant Health Earns 92 RS Rating
Guardant Health earns the No. 12 rank among its peers in the Medical-Services industry group. GeneDx Holdings WGS, Hims & Hers Health HIMS and Stevanato Group STVN are among the top 5 highly rated ...
2don MSN
James Van Der Beek reveals the minor colorectal cancer symptom he dismissed before his diagnosis
James Van Der Beek is sharing the subtle colorectal cancer symptom he ignored before his shocking diagnosis. “There wasn’t ...
James Van Der Beek Gives Life Update Amid Cancer Journey: 'I Was So Emotionally Lit Up' first appeared on Parade on Aug 9, ...
Exact Sciences is paying $75 million for exclusive rights to a blood-based "liquid biopsy" screening test from rival firm ...
Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.
Healthcare distributor and services company McKesson (NYSE:MCK) will be reporting results this Wednesday after market close.
James Van Der Beek has just woken up from a nap as he hops on a Microsoft Teams call.
HealthDay News — Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up colonoscopy (FU-CY) within 6 months, according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results